Since the first successful application of messenger ribonucleic acid (mRNA) as a vaccine agent in clinical studies. Researchers have made many advances in the field of mRNA therapeutic technology after…
Scarlett0318
-
-
The treatment of type 2 diabetes (T2DM) has made impressive progress in the past few decades. Researchers are constantly searching for new treatments. How to control blood glucose and reduce…
-
BusinessHealth
Baloxavir Marboxil for Uncomplicated Influenza: Mechanism of Action & Side Effects
by Scarlett0318by Scarlett0318With thousands of people getting the flu every year, and many people becoming seriously ill, having safe and effective treatment alternatives is critical. Baloxavir marboxil, marketed as Xofluza, is a…
-
BusinessHealth
CDK4/6 Inhibitors for Treatment of Advanced Breast Cancer
by Scarlett0318by Scarlett0318Breast cancer is the most frequent cancer among women, impacting 2.1 million women each year, and also causes the greatest number of cancer-related deaths among women. In 2018, it is…
-
BusinessHealthTechnology
Benefits of Monodisperse PEG Linkers in Drug Development
by Scarlett0318by Scarlett0318The importance of monodisperse poly(ethylene glycols) (PEGs) and their derivatives is rapidly increasing. Monodispersed PEG linkers are pure compounds with a precise, discrete molecular weight. In contrast, polyPEG linkers contain variations…
-
PEGylation has been used in FDA-approved drug therapies and has achieved a successful track record. In 1990, the first PEGylated drug appeared, called Adagen, for the treatment of severe adenosine…